1.
Menopause
; 31(3): 231-233, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38385733
RESUMO
The fractionated CO2 laser has been marketed to women for a variety of gynecologic symptoms and conditions, including the genitourinary syndrome of menopause (GSM). The evidence has been limited, precluding conclusions regarding the efficacy and safety of the therapy. However, data from randomized, controlled trials evaluating this technology for GSM are now available. This Practice Pearl addresses the latest data concerning the use of the fractionated CO2 laser for the treatment of GSM.
Assuntos
Doenças Urogenitais Femininas , Terapia a Laser , Lasers de Gás , Feminino , Humanos , Menopausa , Lasers de Gás/uso terapêutico , Síndrome , Doenças Urogenitais Femininas/cirurgia , Vagina
2.
JAMA Netw Open
; 6(2): e2255706, 2023 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36763366
3.
Lancet
; 393(10188): 2294-2295, 2019 Jun 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31180024